MAZE
MAZE
US5787841007
Maze Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.51B EUR
1.66B EUR
1.48B EUR
2.04B EUR
Enterprise Value
1.09B EUR
1.51B EUR
1.35B EUR
1.88B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-8.41x
--
--
--
Price to Sales
75.3x
82.81x
74.23x
--
Price to Book
3.32x
3.66x
4.34x
5.76x
EV/Revenue
54.35x
75.7x
67.36x
--
EV/EBITDA
-7.56x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.23%
-6.45%
-8.23%
-4.06%
ende